Compare CYTK & SM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYTK | SM |
|---|---|---|
| Founded | 1997 | 1908 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 9.1B |
| IPO Year | 2004 | 1996 |
| Metric | CYTK | SM |
|---|---|---|
| Price | $62.30 | $39.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 18 |
| Target Price | ★ $109.40 | $44.56 |
| AVG Volume (30 Days) | 2.0M | ★ 3.1M |
| Earning Date | 11-04-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.34 |
| Revenue | $13,368,000.00 | ★ $3,154,000,000.00 |
| Revenue This Year | $72.63 | $157.39 |
| Revenue Next Year | $181.06 | $0.50 |
| P/E Ratio | ★ N/A | $11.24 |
| Revenue Growth | N/A | ★ 17.24 |
| 52 Week Low | $54.30 | $17.45 |
| 52 Week High | $88.31 | $41.56 |
| Indicator | CYTK | SM |
|---|---|---|
| Relative Strength Index (RSI) | 36.80 | 64.35 |
| Support Level | $59.21 | $27.39 |
| Resistance Level | $67.65 | $41.56 |
| Average True Range (ATR) | 2.01 | 1.10 |
| MACD | 0.31 | 0.40 |
| Stochastic Oscillator | 34.67 | 98.69 |
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.